new

Get trending papers in your email inbox!

Subscribe

Daily Papers

byAK and the research community

Oct 28

APEX: An Extensible and Dynamism-Aware Simulator for Automated Parallel Execution in LLM Serving

Efficiently serving Large Language Models (LLMs) requires selecting an optimal parallel execution plan, balancing computation, memory, and communication overhead. However, determining the best strategy is challenging due to varying parallelism techniques (data, pipeline, tensor) and workload characteristics (e.g., compute-intensive tasks with long prompts vs. memory-intensive tasks with long generation). We propose APEX, an LLM serving system simulator that efficiently identifies optimal parallel execution plans by considering key factors of LLM serving systems, such as memory usage, batching behavior, etc. APEX performs dynamism-aware simulation to model iteration-level batching, and leverages LLMs' repetitive structure to reduce design space, scaling efficiently to trillion-scale models. APEX abstracts the key components of LLM serving systems, including the model, batching module, quantization formats, and device clusters, enabling the simulator to be general and extensible. Simulating on a CPU, APEX evaluates execution plans for various device clusters, covering diverse LLMs and workloads. APEX finds plans up to 3.37x faster than heuristics, and also plans that reduce energy consumption by up to 45% compared to latency-optimal plans. APEX performs comprehensive evaluations, reporting key system metrics like time per output token and time to first token, which can help service providers meet SLOs. APEX identifies an optimal plan within 15 minutes on a CPU, making it 71x faster and 1234x more cost-effective than cloud-based GPU deployment. APEX can be accessed at https://github.com/microsoft/apex_plus

  • 4 authors
·
Nov 26, 2024

Predicting and generating antibiotics against future pathogens with ApexOracle

Antimicrobial resistance (AMR) is escalating and outpacing current antibiotic development. Thus, discovering antibiotics effective against emerging pathogens is becoming increasingly critical. However, existing approaches cannot rapidly identify effective molecules against novel pathogens or emerging drug-resistant strains. Here, we introduce ApexOracle, an artificial intelligence (AI) model that both predicts the antibacterial potency of existing compounds and designs de novo molecules active against strains it has never encountered. Departing from models that rely solely on molecular features, ApexOracle incorporates pathogen-specific context through the integration of molecular features captured via a foundational discrete diffusion language model and a dual-embedding framework that combines genomic- and literature-derived strain representations. Across diverse bacterial species and chemical modalities, ApexOracle consistently outperformed state-of-the-art approaches in activity prediction and demonstrated reliable transferability to novel pathogens with little or no antimicrobial data. Its unified representation-generation architecture further enables the in silico creation of "new-to-nature" molecules with high predicted efficacy against priority threats. By pairing rapid activity prediction with targeted molecular generation, ApexOracle offers a scalable strategy for countering AMR and preparing for future infectious-disease outbreaks.

  • 4 authors
·
Jul 10